Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. The Company’s scientists have developed a broad platform technology to expand functional cells in culture to create life-saving cures for blood cancers such as leukemia and lymphoma and rare genetic diseases such as sickle cell disease.
Market capitalization (31-Jul-2020)
Closing stock price (31-Jul-2020)
|USD||Q2, 2017||Q2, 2018|
Depreciation and Amortization
Cash From Operating Activities
When was Gamida Cell founded?
Gamida Cell was founded in 1998.
Who are Gamida Cell key executives?
Gamida Cell's key executives are Julian Adams, Josh Hamermesh and Tzvi Palash.
How many employees does Gamida Cell have?
Gamida Cell has 52 employees.
Who are Gamida Cell competitors?
Competitors of Gamida Cell include Monopar Therapeutics, Oncolead and Virttu Biologics.
Where is Gamida Cell headquarters?
Gamida Cell headquarters is located at 673 Boylston St 4th Floor, Boston.
Where are Gamida Cell offices?
Gamida Cell has offices in Boston and Jerusalem.
How many offices does Gamida Cell have?
Gamida Cell has 2 offices.
Receive alerts for 300+ data fields across thousands of companies